William Hall, MD
Radiation Oncology · Milwaukee, WINPI 1104069251
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,971 of the $4,856 with a category attached, or 81.8%. Elekta, Inc. accounts for 94.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $4,350, more than ten times the $326 reported in 2019. Among radiation oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $441.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$5K
- Siemens Medical Solutions USA, Inc.$162
- Boston Scientific$89
Across 19 payments — averaging $33,097 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Elekta Limited$629K
What the payments were for
- Travel & lodging$3,97182%
- Food & beverage$79416%
- Entertainment$912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 9 | $4,605 |
| Siemens Medical Solutions USA, Inc. | 1 | $162 |
| Boston Scientific | 1 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,856 in reported general payments places this provider in the 95th percentile of 131 radiation oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 20 | $148 |
| Famotidine | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Milwaukee
- Joseph BoviMilwaukee$6K
- Lindsay PuckettMilwaukee$4K
- Manpreet BediMilwaukee$3K
- Christopher SchultzMilwaukee$1K
- Beth Erickson-WittmannMilwaukee$1K
- Christina Small-TomMilwaukee$653
- Fan ZhuMilwaukee$590
- Jared RobbinsMilwaukee$448
- Aronne SchottstaedtMilwaukee$247
- Orlando Feliciano LopezMilwaukee$238
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.